» Articles » PMID: 35730070

Contributors to Serum NfL Levels in People Without Neurologic Disease

Overview
Journal Ann Neurol
Specialty Neurology
Date 2022 Jun 22
PMID 35730070
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the effects of demographics, lifestyle factors, and comorbidities on serum neurofilament light chain (sNfL) levels in people without neurologic disease and establish demographic-specific reference ranges of sNfL.

Methods: The National Health and Nutrition Examination Survey (NHANES) is a representative sample of the US population in which detailed information on demographic, lifestyle, routine laboratory tests, and overall health status are systematically collected. From stored serum samples, we measured sNfL levels using a novel high-throughput immunoassay (Siemens Healthineers). We evaluated the predictive capacity of 52 demographic, lifestyle, comorbidity, anthropometric, or laboratory characteristics in explaining variability in sNfL levels. Predictive performance was assessed using cross-validated R (R ) and forward selection was used to obtain a set of best predictors of sNfL levels. Adjusted reference ranges were derived incorporating characteristics using generalized additive models for location, scale, and shape.

Results: We included 1,706 NHANES participants (average age: 43.6 ± 14.8 y; 50.6% male, 35% non-white) without neurological disorders. In univariate models, age explained the most variability in sNfL (R  = 26.8%). Multivariable prediction models for sNfL contained three covariates (in order of their selection): age, creatinine, and glycosylated hemoglobin (HbA1c) (standardized β-age: 0.46, 95% confidence interval [CI]: 0.43, 0.50; creatinine: 0.18, 95% CI: 0.13, 0.22; HbA1c: 0.09, 95% CI: 0.06, 0.11). Adjusted centile curves were derived incorporating identified predictors. We provide an interactive R Shiny application to translate our findings and allow other investigators to use the derived centile curves.

Interpretation: Results will help to guide interpretation of sNfL levels as they relate to neurologic conditions. ANN NEUROL 2022;92:688-698.

Citing Articles

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers.

Thal D, Poesen K, Vandenberghe R, De Meyer S Mol Neurodegener. 2025; 20(1):33.

PMID: 40087672 DOI: 10.1186/s13024-025-00819-y.


Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders.

Sheth U, Oijerstedt L, Heckman M, White L, Heuer H, Lario Lago A Mol Neurodegener. 2025; 20(1):30.

PMID: 40075459 PMC: 11905702. DOI: 10.1186/s13024-025-00821-4.


Association between serum neurofilament light chains and Life's Essential 8: A cross-sectional analysis.

Wang T, Yan L, Ma T, Gao X PLoS One. 2025; 20(2):e0306315.

PMID: 39992894 PMC: 11849891. DOI: 10.1371/journal.pone.0306315.


Exploring the Link Between Renal Function Fluctuations Within the Physiological Range and Serum/CSF Levels of NfL, GFAP, tTAU, and UCHL1.

Koerbel K, Yalachkov Y, Rotter T, Schaller-Paule M, Schaefer J, Friedauer L Int J Mol Sci. 2025; 26(2).

PMID: 39859463 PMC: 11765624. DOI: 10.3390/ijms26020748.


Neurofilament light chain (Nf-L) in cerebrospinal fluid and serum as a potential biomarker in the differential diagnosis of neurological diseases in cattle.

Di Muro G, Tessarolo C, Cagnotti G, Favole A, Ferrini S, Ala U Vet Res. 2025; 56(1):6.

PMID: 39794836 PMC: 11724550. DOI: 10.1186/s13567-024-01441-4.


References
1.
Koini M, Pirpamer L, Hofer E, Buchmann A, Pinter D, Ropele S . Factors influencing serum neurofilament light chain levels in normal aging. Aging (Albany NY). 2021; 13(24):25729-25738. PMC: 8751593. DOI: 10.18632/aging.203790. View

2.
Beydoun M, Noren Hooten N, Maldonado A, Beydoun H, Weiss J, Evans M . BMI and Allostatic Load Are Directly Associated with Longitudinal Increase in Plasma Neurofilament Light among Urban Middle-Aged Adults. J Nutr. 2021; 152(2):535-549. PMC: 8826916. DOI: 10.1093/jn/nxab381. View

3.
Maggi P, Kuhle J, Schadelin S, van der Meer F, Weigel M, Galbusera R . Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis. Neurology. 2021; 97(6):e543-e553. PMC: 8424501. DOI: 10.1212/WNL.0000000000012326. View

4.
Stekhoven D, Buhlmann P . MissForest--non-parametric missing value imputation for mixed-type data. Bioinformatics. 2011; 28(1):112-8. DOI: 10.1093/bioinformatics/btr597. View

5.
Khalil M, Teunissen C, Otto M, Piehl F, Sormani M, Gattringer T . Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018; 14(10):577-589. DOI: 10.1038/s41582-018-0058-z. View